NASDAQ:AEMD
Aethlon Medical Inc.
Aethlon Medical Inc. reported net income of −$7.2M in fiscal 2026. Free cash flow was −$7.0M, and the diluted share count rose 331.8%.Summary generated from Aethlon Medical Inc.'s SEC filings. Latest annual report filed Jun 10, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−142.9%
Debt / equityn/a
Free cash flow−$7.0M
FCF marginn/a
Share count change+331.8%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 | 0 | n/a | n/a |
| Operating income | −10 | −12 | −13 | −9 | −7 |
| Net income | −10 | −12 | −12 | −13 | −7 |
| Free cash flow | −10 | −11 | −10 | −8 | −7 |
Recent filings
- 8-KAmendment to articles or bylaws
Oct 9, 2026 - 8-K/AAmended results of a shareholder vote
Oct 5, 2026 - 8-KDirector or officer change
Oct 1, 2026 - 8-KEntry into a material agreement
Sep 17, 2026 - 8-KDirector or officer change
Sep 15, 2026 - DEF 14AProxy statement
Sep 1, 2026 - 8-KOther events
Aug 31, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026